1. Home
  2. TGTX vs AN Comparison

TGTX vs AN Comparison

Compare TGTX & AN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$55.16

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Logo AutoNation Inc.

AN

AutoNation Inc.

HOLD

Current Price

$166.60

Market Cap

6.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGTX
AN
Founded
1993
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
6.9B
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
TGTX
AN
Price
$55.16
$166.60
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$49.80
$244.33
AVG Volume (30 Days)
1.5M
523.1K
Earning Date
05-04-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
1746.67
0.71
EPS
0.17
11.26
Revenue
$2,785,000.00
$27,631,400,000.00
Revenue This Year
$49.08
$4.32
Revenue Next Year
$26.69
$2.89
P/E Ratio
$341.82
$15.06
Revenue Growth
N/A
3.24
52 Week Low
$26.76
$165.14
52 Week High
$59.30
$235.81

Technical Indicators

Market Signals
Indicator
TGTX
AN
Relative Strength Index (RSI) 61.78 N/A
Support Level $51.76 N/A
Resistance Level $58.12 N/A
Average True Range (ATR) 2.02 0.00
MACD 0.21 0.00
Stochastic Oscillator 84.03 0.00

Price Performance

Historical Comparison
TGTX
AN

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

About AN AutoNation Inc.

AutoNation is the second-largest automotive dealer in the United States, with 2025 revenue of $27.6 billion and over 245 dealerships, plus 52 collision centers. The firm also has 24 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which proved to be a smart move.

Share on Social Networks: